No spreading of immune response against glutamic acid decarboxylase in latent autoimmune diabetes

被引：0
作者：
Ziegler, B
Rjasanowski, I
Strebelow, M
Schlosser, M
Powers, AC
Ziegler, M
机构：
[1] INST DIABET ENDOCRINOL & METAB DIS,KARLSBURG,GERMANY
[2] UNIV GREIFSWALD,CLINICUM KARLSBURG,D-2200 GREIFSWALD,GERMANY
[3] VANDERBILT UNIV,NASHVILLE,TN
来源：
DIABETOLOGIA | 1996年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [31] Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
    Clark, A
    Desai, M
    Cull, CA
    Horton, VA
    Christie, MR
    Bingley, PJ
    Bonifacio, E
    Levy, JC
    Holman, RR
    DIABETOLOGIA, 2005, 48 : A86 - A87
  • [32] Thalamic Lesions in a Toddler with Glutamic Acid Decarboxylase Autoimmune Encephalitis
    AlMuslamani, Ahood
    Taha, Mohamed
    JOURNAL OF PEDIATRIC NEUROLOGY, 2021, 19 (04) : 290 - 294
  • [33] MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy
    Jason R. Fredriksen
    Carrie M. Carr
    Kelly K. Koeller
    Jared T. Verdoorn
    Avi Gadoth
    Sean J. Pittock
    Amy L. Kotsenas
    Neuroradiology, 2018, 60 : 239 - 245
  • [34] MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy
    Fredriksen, Jason R.
    Carr, Carrie M.
    Koeller, Kelly K.
    Verdoorn, Jared T.
    Gadoth, Avi
    Pittock, Sean J.
    Kotsenas, Amy L.
    NEURORADIOLOGY, 2018, 60 (03) : 239 - 245
  • [35] AlemtuzumabPositive autoimmune response of glutamic acid decarboxylase antibodies and islet cell antibodies: case report
    Reactions Weekly, 2019, 1776 (1) : 31 - 31
  • [36] Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults - is it cost-effective?
    Hughes, Lauren E.
    Ford, Clare
    Ekbote, Anjala
    Gama, Rousseau
    ANNALS OF CLINICAL BIOCHEMISTRY, 2017, 54 (05) : 623 - 624
  • [37] Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults
    Maioli, M.
    Pes, G. M.
    Delitala, G.
    Puddu, L.
    Falorni, A.
    Tolu, F.
    Lampis, R.
    Orru, V.
    Secchi, G.
    Cicalo, A. M.
    Floris, R.
    Madau, G. F.
    Pilosu, R. M.
    Whalen, M.
    Cucca, F.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 163 (04) : 541 - 549
  • [38] Glutamic acid decarboxylase immunotherapy for type 1 diabetes
    Ludvigsson, Johnny
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2022, 29 (04) : 361 - 369
  • [39] Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice
    Yamamoto, T
    Yamato, E
    Tashiro, F
    Sato, T
    Noso, S
    Ikegami, H
    Tamura, S
    Yanagawa, Y
    Miyazaki, JI
    DIABETOLOGIA, 2004, 47 (02) : 221 - 224
  • [40] Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase
    H.-S. Jun
    Y.-H. Chung
    J. Han
    A. Kim
    S. Yoo
    R. Sherwin
    J.-W. Yoon
    Diabetologia, 2002, 45 : 668 - 676
12345